Literature DB >> 26769830

Crossfit training changes brain-derived neurotrophic factor and irisin levels at rest, after wingate and progressive tests, and improves aerobic capacity and body composition of young physically active men and women.

E Murawska-Cialowicz1, J Wojna2, J Zuwala-Jagiello3.   

Abstract

Brain-derived neurotrophic factor (BDNF) is a protein that stimulates processes of neurogenesis, the survival of neurons and microglia, stimulates neuroplasticity, and takes part in the differentiation of cells developed in the hippocampus. BDNF is also released from skeletal muscles during exercise and can facilitate cross-talk between the nervous and muscular system. Irisin, the exercise hormone, is also released from skeletal muscles and is involved in oxidation processes in the organism. It is a vital issue from the point of view of prophylaxis and treatment through exercise of age-related diseases (e.g. senile dementia), obesity, type-2 diabetes. The aim of the study was to assess the changes in BDNF and irisin levels in young people after a 3-month CrossFit training program. At baseline and after the training, levels of BDNF and irisin were assayed before and after Wingate and progressive tests. Physical performance, body mass and composition, and muscle circumferences were also measured. There were noted: an improvement in aerobic capacity, an increase in VO2max, a reduction in adipose tissue percentage in women and an increase in LBM in all subjects. After CrossFit training the resting BDNF level increased significantly in all subjects while the resting level of irisin decreased in women, without changes in men. The resting level of BDNF at baseline was higher in men than in women. At baseline we observed an increased level of BDNF in women after Wingate and progressive tests, but in men only after the progressive test. After 3 months of CrossFit training the level of BDNF increased in all subjects, and also was higher in men than in women. In women we did not observe significant differences after both tests in comparison to rest. After the training BDNF was lower in men after Wingate and progressive tests than at rest. At baseline irisin level decreased in women after the Wingate and progressive tests. Changes in men were not observed after both tests. There were no differences in irisin levels between the baseline and 3 months after the training after Wingate and progressive tests. A beneficial influence of CrossFit training on the subjects' body composition, anaerobic capacity and cardiovascular fitness as well as an increase in BDNF makes it possible to assume that this type of training could have a very high application value, especially in a therapeutic process leading to improving a patient's wellbeing.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26769830

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  47 in total

1.  CrossFit® Training Strategies from the Perspective of Concurrent Training: A Systematic Review.

Authors:  Petr Schlegel
Journal:  J Sports Sci Med       Date:  2020-11-19       Impact factor: 2.988

2.  Functional high-intensity exercise training ameliorates insulin resistance and cardiometabolic risk factors in type 2 diabetes.

Authors:  Ciarán E Fealy; Stephan Nieuwoudt; Julie A Foucher; Amanda R Scelsi; Steven K Malin; Mangesh Pagadala; Lauren A Cruz; Miranda Li; Michael Rocco; Bartolome Burguera; John P Kirwan
Journal:  Exp Physiol       Date:  2018-07       Impact factor: 2.969

3.  Sedentary patterns are associated with BDNF in patients with type 2 diabetes mellitus.

Authors:  Pedro B Júdice; João P Magalhães; Megan Hetherington-Rauth; Inês R Correia; Luís B Sardinha
Journal:  Eur J Appl Physiol       Date:  2021-01-02       Impact factor: 3.078

4.  How training loads in the preparation and competitive period affect the biochemical indicators of training stress in youth soccer players?

Authors:  Marcin Andrzejewski; Jakub Kryściak; Marek Konefał; Tomasz Podgórski; Beata Pluta; Paweł Chmura; Jan Chmura; Jakub Marynowicz; Kamil Melka; Marius Brazaitis
Journal:  PeerJ       Date:  2022-05-05       Impact factor: 3.061

5.  Injury Incidence and Patterns Among Dutch CrossFit Athletes.

Authors:  Mirwais Mehrab; Robert-Jan de Vos; Gerald A Kraan; Nina M C Mathijssen
Journal:  Orthop J Sports Med       Date:  2017-12-18

6.  Effects of physical activity on the link between PGC-1a and FNDC5 in muscle, circulating Ιrisin and UCP1 of white adipocytes in humans: A systematic review.

Authors:  Petros C Dinas; Ian M Lahart; James A Timmons; Per-Arne Svensson; Yiannis Koutedakis; Andreas D Flouris; George S Metsios
Journal:  F1000Res       Date:  2017-03-17

Review 7.  Exercise-dependent BDNF as a Modulatory Factor for the Executive Processing of Individuals in Course of Cognitive Decline. A Systematic Review.

Authors:  Gilmara G de Assis; Katie Moraes de Almondes
Journal:  Front Psychol       Date:  2017-04-19

8.  The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis.

Authors:  Adam Dinoff; Nathan Herrmann; Walter Swardfager; Celina S Liu; Chelsea Sherman; Sarah Chan; Krista L Lanctôt
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

9.  The Alteration of Irisin-Brain-Derived Neurotrophic Factor Axis Parallels Severity of Distress Disorder in Bronchial Asthma Patients.

Authors:  Magdolna E Szilasi; Krisztian Pak; Laszlo Kardos; Viktoria E Varga; Ildiko Seres; Angela Mikaczo; Andrea Fodor; Maria Szilasi; Gabor Tajti; Csaba Papp; Rudolf Gesztelyi; Judit Zsuga
Journal:  Front Neurosci       Date:  2017-11-23       Impact factor: 4.677

Review 10.  CrossFit Overview: Systematic Review and Meta-analysis.

Authors:  João Gustavo Claudino; Tim J Gabbett; Frank Bourgeois; Helton de Sá Souza; Rafael Chagas Miranda; Bruno Mezêncio; Rafael Soncin; Carlos Alberto Cardoso Filho; Martim Bottaro; Arnaldo Jose Hernandez; Alberto Carlos Amadio; Julio Cerca Serrão
Journal:  Sports Med Open       Date:  2018-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.